Scientists Must Speed Up Transfer Of Supercomputing Technology

Although the United States continues to be recognized as a world leader in science, our industries have increasingly been buffeted by global competition. Other nations, particularly Japan, have often been swifter than we in moving their own scientific and technological advances from the laboratory to the marketplace. Supercomputing offers an opportunity for the United States to address these problems, using a homegrown technology in which we still maintain a lead. For example, circuit simulati

Written byIrving Wladawsky-berger
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Although the United States continues to be recognized as a world leader in science, our industries have increasingly been buffeted by global competition. Other nations, particularly Japan, have often been swifter than we in moving their own scientific and technological advances from the laboratory to the marketplace.

Supercomputing offers an opportunity for the United States to address these problems, using a homegrown technology in which we still maintain a lead. For example, circuit simulation that might take two months on a minicomputer can be done in about a day on a supercomputer. Such quick turnarounds can make the difference between whether work is done computationally or done through costly and lengthy prototyping and product testing.

Further improvements in cost and performance could make these powerful tools available to a wide range of industrial users, including even small and mid-size companies. Supercomputers available by the mid-1990s are expected to be at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies